°¡Å縯´ëÇб³ ¼¿ï¼º¸ðº´¿ø Á¶Ç÷¸ð¼¼Æ÷À̽ļ¾ÅÍ ÀÌÁ¾¿í ±³¼ö°¡ Áö³ 8¿ù 27ÀϺÎÅÍ 29ÀϱîÁö ¼¿ï±×·£µåÈúÆ°È£ÅÚ¿¡¼ °³ÃÖµÈ Á¦14Â÷ ¾Æ-Å Á¶Ç÷¸ð¼¼Æ÷À̽ÄÇÐȸ(14thCongress of the Asia-Pacific Blood and Marrow Transplantation : APBMT2009)¿¡¼ ÃÖ¿ì¼ö¿¬Á¦»ó(Best oral presentation award)À» ¼ö»óÇß´Ù.
À̹ø ÇÐȸ´Â ¾Æ-Å Áö¿ª 17°³ ³ª¶óÀÇ Á¶Ç÷¸ð¼¼Æ÷À̽ĺоßÀÇ Àü¹®°¡ ¾à 500¸íÀÌ Âü¼®ÇØ °¢ ³ª¶óÀÇ À̽ÄÇöȲ ¹× Àӻ󿬱¸¿¡ ´ëÇØ È°¹ßÇÑ Åä·ÐÀ» °¡Áø ÀÚ¸®·Î ¸¶·ÃµÅ ³ôÀº °ü½ÉÀ» ¸ð¾Ò´Ù.
ÁßÁõÀç»ýºÒ·®¼ººóÇ÷ȯÀÚ¿¡¼ ºñÇ÷¿¬°£(ŸÀΰ£) Á¶Ç÷¸ð¼¼Æ÷À̽ÄÀÇ ¼º°ø·üÀº Àü¼¼°èÀûÀ¸·Î ¾à 60%ÀÇ ¼öÁØÀ¸·Î ÀÌ½Ä ÈÄ °ÅºÎ¹ÝÀÀ ¹× À̽İú °ü·ÃµÈ ÇÕº´Áõ µîÀÌ ÁÖµÈ ½ÇÆÐÀÇ ¿øÀÎÀ̾ú´Ù. ÀÌ ±³¼ö´Â‘The outcome of unrelated hematopoietic stem cell transplants with total body irradiation (800cGy) and cyclophosphamide (120mg/kg) in adult patients with severe aplastic anemia(¼ºÀÎ ÁßÁõÀç»ýºÒ·®¼ººóÇ÷ȯÀÚ¿¡¼ Àü½Å¹æ»ç¼±Á¶»ç(800cGy)¿Í »çÀÌŬ·ÎÆ÷½ºÆĸ¶À̵å (120mg/kg)ÀÇ ÀÌ½Ä Àü óġ¸¦ ÀÌ¿ëÇÑ ºñÇ÷¿¬°£ Á¶Ç÷¸ð¼¼Æ÷À̽Ä)’ÁÖÁ¦·Î ±âÁ¸ÀÇ ¹®Á¦Á¡µéÀ» ±Øº¹Çϱâ À§ÇØ ¹æ»ç¼±Ä¡·á ¹× ¸é¿ª¾ïÁ¦Á¦ÀÇ ÀûÀýÇÑ ÀÌ½Ä Àüóġ¿ä¹ýÀ» °³¹ß, 88%ÀÇ ³î¶ó¿î ¼º°ø·ü(Àå±â»ýÁ¸À²)À» º¸°íÇØ ¾Æ-Å Á¶Ç÷¸ð¼¼Æ÷À̽ÄÀü¹®°¡µé·ÎºÎÅÍ Âù»ç¸¦ ¹Þ¾Ò´Ù.
ÀÌ ±³¼ö´Â ÇöÀç °¡Å縯¼¼Æ÷Ä¡·á»ç¾÷´Ü ´ÜÀå, °¡Å縯ÀÇ°ú´ëÇÐ Ç÷¾×³»°ú ÇаúÀå ¹× ¼¿ï¼º¸ðº´¿ø Ç÷¾×³»°ú ºÐ°úÀåÀ» ¸Â°í ÀÖÀ¸¸ç, ´ëÇÑÇ÷¾×ÇÐȸ Àç»ýºÒ·®¼ººóÇ÷¿¬±¸È¸ À§¿øÀåÀ¸·Î È°µ¿ÁßÀÌ´Ù.